3rd Quarter - Report
MCDERMOTT+ LLC for CVS HEALTH
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General issues relating to PBMs. Issues relating to prescription drug pricing, including H.R. 3 Lower Drug Costs Now Act of 2019, S. 1895 Lower Health Care Costs Act, and S. 2543 The Prescription Drug Pricing Reduction Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE WALDO | — |
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Health Issues HCR
General issues relating to PBMs. Issues relating to prescription drug pricing, including H.R. 3 Lower Drug Costs Now Act of 2019, S. 1895 Lower Health Care Costs Act, and S. 2543 The Prescription Drug Pricing Reduction Act of 2019.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE WALDO | — |
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.